General and abdominal obesity and incident hypertension among people living with HIV on antiretroviral therapy

被引:6
作者
Xu, Xiaohui [1 ]
Chen, Xiaoxiao [2 ]
Lin, Haijiang [2 ]
Zhu, Bowen [3 ]
Shen, Weiwei [2 ]
Shi, Ruizi [1 ]
Xu, Xiaoyi [1 ]
He, Na [1 ,3 ]
Ding, Yingying [1 ,3 ]
机构
[1] Fudan Univ, Sch Publ Hlth, Minist Educ, Dept Epidemiol,Key Lab Publ Hlth Safety, POB 289,138 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China
[2] Taizhou City Ctr Dis Control & Prevent, Taizhou City, Peoples R China
[3] Fudan Univ, Minist Hlth, Key Lab Hlth Technol Assessment, Shanghai, Peoples R China
来源
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV | 2021年 / 33卷 / 12期
关键词
Hypertension; HIV; abdominal obesity; general obesity;
D O I
10.1080/09540121.2020.1852158
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Hypertension is highly prevalent among people living with HIV (PLWH). We sought to characterize the hypertension incidence among PLWH on antiretroviral therapy, focusing on the effect of change in general and abdominal obesity on hypertension during follow-up. This was a prospective analysis of 229 treated PLWH aged over 40 years without hypertension at baseline. Overall a median follow-up of 2.9 years, 26.2% PLWH developed hypertension. In multivariable models, compared to those without obesity measures at both baseline and follow-up visit, PLWH with general obesity at both occasions (adjusted odds ratio [aOR] = 3.83, P = 0.006) or at baseline only (aOR = 5.45, P = 0.003), abdominal obesity (measured as waist circumference) at both occasions (aOR = 3.87, P = 0.001) or at follow-up only (aOR = 2.27; 9P = 0.060), abdominal obesity (measured as waist-to-hip ratio) at both occasions (aOR = 2.27, P = 0.077) were at increased risk of incident hypertension. Our data show that both general and abdominal obesity especially in the persistent status increase the hypertension risk in treated PLWH.
引用
收藏
页码:1616 / 1620
页数:5
相关论文
共 23 条
[1]  
[Anonymous], 2014, CLIN INFECT DIS, V58, pi
[2]  
BATAVIA AS, 2018, J HYPERTENSION, V36
[3]   Longitudinal anthropometric changes in HIV-infected and HIV-uninfected men [J].
Brown, Todd ;
Wang, Zhaojie ;
Chu, Haito ;
Palella, Frank J. ;
Kingsley, Lawrence ;
Witt, Mallory D. ;
Dobs, Adrian S. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 43 (03) :356-362
[4]   Risk indicators and effects of hypertension on HIV/AIDS disease progression among patients seen at Kenyatta hospital HIV care center [J].
Chepchirchir, Angeline ;
Jaoko, Walter ;
Nyagol, Joshua .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2018, 30 (05) :544-550
[5]  
DING Y, 2017, AIDS RES HUMAN RETRO, V33
[6]   Hypertension in HIV-Infected Adults Novel Pathophysiologic Mechanisms [J].
Fahme, Sasha A. ;
Bloomfield, Gerald S. ;
Peck, Robert .
HYPERTENSION, 2018, 72 (01) :44-55
[7]   Central/Peripheral Fat Mass Ratio Is Associated With Increased Risk of Hypertension in HIV-Infected Patients [J].
Freitas, Paula ;
Carvalho, Davide ;
Santos, Ana Cristina ;
Madureira, Antonio Jose ;
Xerinda, Sandra ;
Martinez, Esteban ;
Pereira, Jorge ;
Sarmento, Antonio ;
Medina, Jose Luis .
JOURNAL OF CLINICAL HYPERTENSION, 2012, 14 (09) :593-600
[8]   Higher Risk of Abdominal Obesity, Elevated Low-Density Lipoprotein Cholesterol, and Hypertriglyceridemia, but not of Hypertension, in People Living With Human Immunodeficiency Virus (HIV): Results From the Copenhagen Comorbidity in HIV Infection Study [J].
Gelpi, Marco ;
Afzal, Shoaib ;
Lundgren, Jens ;
Ronit, Andreas ;
Roen, Ashley ;
Mocroft, Amanda ;
Gerstoft, Jan ;
Lebech, Anne-Mette ;
Lindegaard, Birgitte ;
Kofoed, Klaus Fuglsang ;
Nordestgaard, Borge G. ;
Nielsen, Susanne Dam .
CLINICAL INFECTIOUS DISEASES, 2018, 67 (04) :579-586
[9]   Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study [J].
Hatleberg, C. I. ;
Ryom, L. ;
Monforte, A. d'Arminio ;
Fontas, E. ;
Reiss, P. ;
Kirk, O. ;
El-Sadr, W. ;
Phillips, A. ;
de Wit, S. ;
Dabis, F. ;
Weber, R. ;
Law, M. ;
Lundgren, J. D. ;
Sabin, C. .
HIV MEDICINE, 2018, 19 (09) :605-618
[10]  
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1995, IARC Monogr Eval Carcinog Risks Hum, V64, P1